狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            您好, 歡迎來(lái)到化工儀器網(wǎng)

            | 注冊(cè)| 產(chǎn)品展廳| 收藏該商鋪

            18611095289

            news

            首頁(yè)   >>   公司動(dòng)態(tài)   >>   Biomedica 公司NT-proBNP ELISA Kit 簡(jiǎn)介

            北京博蕾德科技發(fā)展有限公...

            立即詢(xún)價(jià)

            您提交后,專(zhuān)屬客服將第一時(shí)間為您服務(wù)

            Biomedica 公司NT-proBNP ELISA Kit 簡(jiǎn)介

            閱讀:1159      發(fā)布時(shí)間:2014-3-23
            分享:

            NT-proBNP ELISA Kit (Cat.No.SK-1204)

            為什么要檢測(cè)NT-proBNP ?

            NT-proBNP proBNP分解后的76氨基酸片段。proBNP是心臟為彌補(bǔ)收縮無(wú)力而增大時(shí),心壁被拉伸時(shí)由心臟釋放到血液中的化學(xué)物質(zhì)。一旦從心臟釋放到血液中,proBNP就會(huì)分割為NT-proBNPBNP。由于NT-proBNP的半衰期為120min,相比之下,BNP的半衰期僅20min。所以NT-proBNP可追蹤的時(shí)間可達(dá)24hBNPzui多可監(jiān)測(cè)的時(shí)間為1h。因此,檢測(cè)血清/血漿中的NT-proBNP穩(wěn)定性更好,檢測(cè)結(jié)果更可靠,是有效的心衰檢測(cè)工具。

            應(yīng)用領(lǐng)域:

            1. 心臟衰竭、急性心肌梗死(左心室功能不全)
            2. 腎衰竭
            3. 肥胖癥和糖尿病
            4. 各種形式的繼發(fā)性高血壓
            5. 心衰患者的療效監(jiān)測(cè)

            產(chǎn)品優(yōu)勢(shì):

            1. 性?xún)r(jià)比高
            2. 可用于每個(gè)實(shí)驗(yàn)室或開(kāi)放實(shí)驗(yàn)室
            3. CE 標(biāo)志-可用于臨床診斷
            4. 簡(jiǎn)單-傳統(tǒng)96孔板
            5. 動(dòng)態(tài)檢測(cè)范圍廣-可用于早期心衰檢測(cè)

            試劑盒特點(diǎn):

            檢測(cè)方法:夾心ELISA,HRP/TMB顯色,12x8 板條

            樣本類(lèi)型:血清

            樣品量:50ul/test

            標(biāo)準(zhǔn)品范圍:0-640 pmol/L

            檢測(cè)靈敏度:3pmol/L

            孵育條件:3h/30min

            單位換算:1pmol/L=8.475pg/ml

            參考文獻(xiàn):

            1

            Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide. PRZEMYSLAW J,et al. J Rheumatol, Apr 2012; 39: 701 - 706.

            2

            Left Ventricular Function Impairment in Patients With Normal-Weight Obesity:

            Contribution of Abdominal Fat Deposition, Profibrotic State, Reduced Insulin

            Sensitivity, and Proinflammatory Activation. Wojciech Kosmala,et al. Circ Cardiovasc Imaging, May 2012; 5: 349 - 356.

            3

            Prognostic value of left atrial expansion index and exercise-induced change in atrial natriuretic peptide as long-term predictors of atrial fibrillation recurrence..Malini Govindan,et al. Europace, Sep 2012; 14: 1302 - 1310.

            4

            Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl

            oxidase? Begoña López,et al. Cardiovasc Res, Jul 2013; 99: 111 - 120. 

            5

            High-sensitivity troponin assay improves prediction of cardiovascular risk in

            patients with cerebral ischaemia. Raoul Stahrenberg,et al. J. Neurol. Neurosurg. Psychiatry, May 2013; 84: 479 - 487.

            6

            Translational phases of evidence in a prognostic biomarker: a systematic review and meta-analysis of natriuretic peptides and the prognosis of stable coronary disease. Shailen Sutaria,et al. Heart, Apr 2012; 98: 615 - 622. 

            7

            Prognostic impact of body mass index in patients undergoing coronary artery

            bypass surgery. Shih-Hsien Sung,et al. Heart, Apr 2011; 97: 648 - 654.

            8

            Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus

            scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Afif F EL-Khuffash,et al. Arch. Dis. Child. Fetal Neonatal Ed., Mar 2011; 96: F133 - F137. 

            9

            Multidimensional assessment of older people with asthma and COPD: clinical

            management and health status. Vanessa M. McDonald,et al. Age Ageing, Jan 2011; 40: 42 – 49

            10

            Diagnostic value of NT-proBNP in identifying aortic stenosis patients with heart failure. C Wu,et al. Zhonghua Xin Xue Guan Bing Za Zhi, Jul 2010; 38(7): 579-83.

            11

            Pulmonary arterial hypertension in rheumatic mitral stenosis: does it affect right

            ventricular function and outcome after mitral valve replacement? Shantanu Pande,et al. Interact CardioVasc Thorac Surg, Sep 2009; 9: 421 - 425

            12

            Pulmonary arterial hypertension in rheumatic mitral stenosis: does it affect right

            ventricular function and outcome after mitral valve replacement? Shantanu Pande,et al. Interactive CardioVascular and Thoracic Surgery, Sep 2009; 9: 421 - 425.

            13

            Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular

            function in patients with symptomatic heart failure. John K. Kjekshus,et al. Eur J Heart Fail, Aug 2009; 11: 771 – 778

            14

            Prevalence of Left Ventricular Diastolic Dysfunction in a General Population. Tatiana Kuznetsova,et al. Circ Heart Fail, Mar 2009; 2: 105 - 112.

             

            會(huì)員登錄

            請(qǐng)輸入賬號(hào)

            請(qǐng)輸入密碼

            =

            請(qǐng)輸驗(yàn)證碼

            收藏該商鋪

            標(biāo)簽:
            保存成功

            (空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

            常用:

            提示

            您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
            在線(xiàn)留言